Clearmind Medicine (CMND) Amortizatization of Intangibles (2022 - 2026)

Clearmind Medicine's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $2671.0 for Q2 2026.

• In Q2 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $2671.0; the TTM figure through Apr 2026 stood at $10954.0 (changed 0.0% YoY), while the FY2025 annual figure was $10954.0, changed 0.27% from the prior year.
• Amortizatization of Intangibles for Q2 2026 stood at $2671.0, down from $2761.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $12.3 billion in Q3 2022, with the low at -$12.3 billion in Q4 2022.
• The 5-year median for Amortizatization of Intangibles is $2761.0 (2024), against an average of $3018.4.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles sank 100.0% in 2023, then surged 277.56% in 2024.
• Clearmind Medicine's Amortizatization of Intangibles stood at -$12.3 billion in 2022, then soared by 100.0% to -$1555.0 in 2023, then soared by 277.56% to $2761.0 in 2024, then changed by 0.0% to $2761.0 in 2025, then retreated by 3.26% to $2671.0 in 2026.
• Business Quant data shows CMND's Amortizatization of Intangibles at $2671.0 in Q2 2026, $2761.0 in Q1 2026, and $2761.0 in Q4 2025.